5VTA | pdb_00005vta

Co-Crystal Structure of DPPIV with a Chemibody Inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.80 Å
  • R-Value Free: 
    0.300 (Depositor), 0.300 (DCC) 
  • R-Value Work: 
    0.250 (Depositor), 0.253 (DCC) 
  • R-Value Observed: 
    0.252 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 5VTA

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Structure-guided Discovery of Dual-recognition Chemibodies.

Cheng, A.C.Doherty, E.M.Johnstone, S.DiMauro, E.F.Dao, J.Luthra, A.Ye, J.Tang, J.Nixey, T.Min, X.Tagari, P.Miranda, L.P.Wang, Z.

(2018) Sci Rep 8: 7570-7570

  • DOI: https://doi.org/10.1038/s41598-018-25848-0
  • Primary Citation Related Structures: 
    5VTA

  • PubMed Abstract: 

    Small molecules and antibodies each have advantages and limitations as therapeutics. Here, we present for the first time to our knowledge, the structure-guided design of "chemibodies" as small molecule-antibody hybrids that offer dual recognition of a single target by both a small molecule and an antibody, using DPP-IV enzyme as a proof of concept study. Biochemical characterization demonstrates that the chemibodies present superior DPP-IV inhibition compared to either small molecule or antibody component alone. We validated our design by successfully solving a co-crystal structure of a chemibody in complex with DPP-IV, confirming specific binding of the small molecule portion at the interior catalytic site and the Fab portion at the protein surface. The discovery of chemibodies presents considerable potential for novel therapeutics that harness the power of both small molecule and antibody modalities to achieve superior specificity, potency, and pharmacokinetic properties.


  • Organizational Affiliation
    • Department of Therapeutic Discovery, Amgen Discovery Research, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA, 94080, USA.

Macromolecule Content 

  • Total Structure Weight: 535.92 kDa 
  • Atom Count: 33,875 
  • Modeled Residue Count: 4,161 
  • Deposited Residue Count: 4,676 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Dipeptidyl peptidase 4
A, B, C, D
739Rattus norvegicusMutation(s): 0 
Gene Names: Dpp4Cd26
EC: 3.4.14.5
UniProt
Find proteins for P14740 (Rattus norvegicus)
Explore P14740 
Go to UniProtKB:  P14740
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP14740
Glycosylation
Glycosylation Sites: 6Go to GlyGen: P14740-1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Fab light chainE [auth L],
F [auth E],
I [auth G],
K [auth J]
213Mus musculusMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
Fab heavy chainG [auth H],
H [auth F],
J [auth I],
L [auth K]
217Mus musculusMutation(s): 0 

Small Molecules

Ligands 5 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
9K4

Query on 9K4



Download:Ideal Coordinates CCD File
EA [auth B],
QA [auth C],
Y [auth A],
YA [auth D]
2-{4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]piperazin-1-yl}-N-(22-oxo-3,6,9,12,15,18-hexaoxa-21-azatricosan-1-yl)acetamide
C32 H52 F3 N5 O9
UFCDLSMAWGWQEO-HHHXNRCGSA-N
NAG

Query on NAG



Download:Ideal Coordinates CCD File
AA [auth B]
BA [auth B]
CA [auth B]
FA [auth C]
GA [auth C]
AA [auth B],
BA [auth B],
CA [auth B],
FA [auth C],
GA [auth C],
HA [auth C],
IA [auth C],
JA [auth C],
KA [auth C],
M [auth A],
N [auth A],
O [auth A],
P [auth A],
Q [auth A],
RA [auth D],
SA [auth D],
TA [auth D],
UA [auth D],
VA [auth D],
WA [auth D],
Z [auth B]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
PG4

Query on PG4



Download:Ideal Coordinates CCD File
R [auth A]TETRAETHYLENE GLYCOL
C8 H18 O5
UWHCKJMYHZGTIT-UHFFFAOYSA-N
PEG

Query on PEG



Download:Ideal Coordinates CCD File
S [auth A],
T [auth A],
XA [auth D]
DI(HYDROXYETHYL)ETHER
C4 H10 O3
MTHSVFCYNBDYFN-UHFFFAOYSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
DA [auth B]
LA [auth C]
MA [auth C]
NA [auth C]
OA [auth C]
DA [auth B],
LA [auth C],
MA [auth C],
NA [auth C],
OA [auth C],
PA [auth C],
U [auth A],
V [auth A],
W [auth A],
X [auth A]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.80 Å
  • R-Value Free:  0.300 (Depositor), 0.300 (DCC) 
  • R-Value Work:  0.250 (Depositor), 0.253 (DCC) 
  • R-Value Observed: 0.252 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 120.325α = 62.34
b = 123.229β = 77.21
c = 129.018γ = 75.91
Software Package:
Software NamePurpose
REFMACrefinement
SCALAdata scaling
PDB_EXTRACTdata extraction
MOSFLMdata reduction
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2018-05-09
    Type: Initial release
  • Version 1.1: 2018-05-30
    Changes: Data collection, Database references
  • Version 1.2: 2020-07-29
    Type: Remediation
    Reason: Carbohydrate remediation
    Changes: Data collection, Derived calculations, Structure summary
  • Version 1.3: 2024-11-13
    Changes: Data collection, Database references, Structure summary